Votrient
/
Votrient (pazopanib) is a targeted therapy classified as a tyrosine kinase inhibitor, used for the treatment of advanced renal cell carcinoma and soft tissue sarcoma. It is administered as an oral tablet and is available by prescription only. Patients are advised that Votrient may cause liver problems and should not be used in individuals with severe liver impairment.
FAQs about Votrient
What should I do if I miss a dose?
If you miss a dose of Votrient, take it as soon as you remember on the same day. However, if it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not take two doses at the same time to make up for a missed dose. This information is provided in the Patient Counseling Information section of the label.
Can I stop taking Votrient suddenly?
The label advises against abruptly discontinuing Votrient without consulting your healthcare provider. Stopping the medication suddenly may lead to a worsening of your condition. Always discuss any changes to your treatment plan with your prescriber.
Can I take Votrient while pregnant or breastfeeding?
The use of Votrient during pregnancy is not recommended, as it may harm the fetus. Women who are breastfeeding should not take Votrient, as it is not known if the drug passes into breast milk. This information is detailed in the Warnings and Precautions section of the label.
How should I store Votrient?
Votrient should be stored at room temperature, away from moisture and heat. Keep the medication in its original container and out of reach of children. This storage information is outlined in the Storage section of the label.
25
commonly-prescribed
medication.